Revenue for the quarter grew 63.7% year-on-year to ₹516 crore from ₹315.2 crore in Q2 FY25. Earnings before interest, tax, depreciation, and amortisation (EBITDA) increased to ₹156.9 crore from ₹65.7 crore a year ago. Shares of Neuland Laboratories Ltd ended at ₹17,760.00, up by ₹207.15, or 1.18%, on the BSE.
